Electrical
biosensors, including transistor-based devices
(i.e.,
BioFETs), have the potential to offer versatile biomarker detection
in a simple, low-cost, scalable, and point-of-care manner. Semiconducting
carbon nanotubes (CNTs) are among the most explored nanomaterial candidates
for BioFETs due to their high electrical sensitivity and compatibility
with diverse fabrication approaches. However, when operating in solutions
at biologically relevant ionic strengths, CNT-based BioFETs suffer
from debilitating levels of signal drift and charge screening, which
are often unaccounted for or sidestepped (but not addressed) by testing
in diluted solutions. In this work, we present an ultrasensitive CNT-based
BioFET called the D4-TFT, an immunoassay with an electrical readout,
which overcomes charge screening and drift-related limitations of
BioFETs. In high ionic strength solution (1X PBS), the D4-TFT repeatedly
and stably detects subfemtomolar biomarker concentrations in a point-of-care
form factor by increasing the sensing distance in solution (Debye
length) and mitigating signal drift effects. Debye length screening
and biofouling effects are overcome using a poly(ethylene glycol)-like
polymer brush interface (POEGMA) above the device into which antibodies
are printed. Simultaneous testing of a control device having no antibodies
printed over the CNT channel confirms successful detection of the
target biomarker via an on-current shift caused by antibody sandwich
formation. Drift in the target signal is mitigated by a combination
of: (1) maximizing sensitivity by appropriate passivation alongside
the polymer brush coating; (2) using a stable electrical testing configuration;
and (3) enforcing a rigorous testing methodology that relies on infrequent
DC sweeps rather than static or AC measurements. These improvements
are realized in a relatively simple device using printed CNTs and
antibodies for a low-cost, versatile platform for the ongoing pursuit
of point-of-care BioFETs.